S&P 500   3,086.13 (-0.18%)
DOW   27,671.64 (-0.07%)
QQQ   201.28 (-0.13%)
CGC   19.22 (-0.16%)
BABA   184.77 (-1.18%)
GE   11.30 (-1.05%)
T   39.13 (-0.10%)
F   8.97 (-0.77%)
ACB   3.56 (-0.28%)
PRI   128.40 (-1.19%)
BAC   32.73 (-1.12%)
DIS   138.60 (+0.01%)
S&P 500   3,086.13 (-0.18%)
DOW   27,671.64 (-0.07%)
QQQ   201.28 (-0.13%)
CGC   19.22 (-0.16%)
BABA   184.77 (-1.18%)
GE   11.30 (-1.05%)
T   39.13 (-0.10%)
F   8.97 (-0.77%)
ACB   3.56 (-0.28%)
PRI   128.40 (-1.19%)
BAC   32.73 (-1.12%)
DIS   138.60 (+0.01%)
Log in

Innophos Stock Price, Forecast & Analysis (NASDAQ:IPHS)

$32.03
+0.01 (+0.03 %)
(As of 11/13/2019 08:57 AM ET)
Today's Range
$31.93
Now: $32.03
$32.08
50-Day Range
$30.31
MA: $32.48
$35.42
52-Week Range
$22.57
Now: $32.03
$37.53
Volume120,700 shs
Average Volume116,864 shs
Market Capitalization$630.70 million
P/E Ratio14.05
Dividend Yield6.00%
Beta1.44
Innophos Holdings, Inc, together with its subsidiaries, produces specialty ingredients with applications in food, health, nutrition, and industrial markets. It operates through three segments: Food, Health and Nutrition; Industrial Specialties; and Other. The company's specialty ingredients include specialty phosphate salts and specialty phosphoric acids, as well as other mineral, enzyme, and botanical based specialty ingredients that are used as flavor enhancers in beverages; electrolytes in sports drinks; texture modifiers in cheeses; leavening agents in baked goods; calcium and phosphorus fortification in food and beverages; moisture and color retention in seafood, poultry, and meat; excipients in vitamins, minerals, nutritional supplements, and pharmaceuticals; and abrasives in toothpaste. Read More…

Industry, Sector and Symbol

Industry Chemicals & allied products
Sub-IndustrySpecialty Chemicals
SectorBasic Materials
Current SymbolNASDAQ:IPHS
CUSIP45774N10
Phone609-495-2495

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$801.84 million
Cash Flow$4.60 per share
Book Value$17.10 per share

Profitability

Net Income$36.07 million

Miscellaneous

Employees1,485
Market Cap$630.70 million
Next Earnings Date2/19/2020 (Estimated)
OptionableOptionable

Receive IPHS News and Ratings via Email

Sign-up to receive the latest news and ratings for IPHS and its competitors with MarketBeat's FREE daily newsletter.


Innophos (NASDAQ:IPHS) Frequently Asked Questions

What is Innophos' stock symbol?

Innophos trades on the NASDAQ under the ticker symbol "IPHS."

How often does Innophos pay dividends? What is the dividend yield for Innophos?

Innophos declared a quarterly dividend on Tuesday, August 6th. Shareholders of record on Friday, August 23rd will be paid a dividend of $0.48 per share on Friday, September 6th. This represents a $1.92 annualized dividend and a yield of 5.99%. The ex-dividend date is Thursday, August 22nd. View Innophos' Dividend History.

How were Innophos' earnings last quarter?

Innophos Holdings, Inc. (NASDAQ:IPHS) announced its quarterly earnings data on Wednesday, November, 6th. The specialty chemicals company reported $0.45 EPS for the quarter, missing the consensus estimate of $0.55 by $0.10. The specialty chemicals company earned $189 million during the quarter, compared to the consensus estimate of $185.55 million. Innophos had a return on equity of 11.56% and a net margin of 2.82%. The business's revenue for the quarter was down 4.1% on a year-over-year basis. During the same quarter last year, the firm earned $0.58 earnings per share. View Innophos' Earnings History.

When is Innophos' next earnings date?

Innophos is scheduled to release their next quarterly earnings announcement on Wednesday, February 19th 2020. View Earnings Estimates for Innophos.

What guidance has Innophos issued on next quarter's earnings?

Innophos updated its third quarter 2019 earnings guidance on Monday, October, 21st. The company provided EPS guidance of for the period. The company issued revenue guidance of $190-190 million, compared to the consensus revenue estimate of $185.55 million.

What is the consensus analysts' recommendation for Innophos?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Innophos in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Innophos.

Has Innophos been receiving favorable news coverage?

News articles about IPHS stock have been trending very negative on Wednesday, according to InfoTrie Sentiment. InfoTrie identifies positive and negative media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Innophos earned a news sentiment score of -3.2 on InfoTrie's scale. They also assigned media stories about the specialty chemicals company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the stock's share price in the next few days. View News Stories for Innophos.

Who are some of Innophos' key competitors?

What other stocks do shareholders of Innophos own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Innophos investors own include Applied Materials (AMAT), Intel (INTC), Energy Transfer LP Unit (ET), Freeport-McMoRan (FCX), 3M (MMM), Allena Pharmaceuticals (ALNA), Costco Wholesale (COST), Cisco Systems (CSCO), FireEye (FEYE) and Texas Instruments (TXN).

Who are Innophos' key executives?

Innophos' management team includes the folowing people:
  • Dr. Kim Ann Mink, Chairman, CEO & Pres (Age 59)
  • Mr. Hermanus Kieftenbeld, Sr. VP & CFO (Age 53)
  • Ms. Sherry Duff, Sr. VP and Chief Marketing & Technology Officer (Age 51)
  • Mr. Joshua Horenstein, Sr. VP, Chief Legal Officer & Corp. Sec. (Age 42)
  • Ms. Amy Hartzell, Sr. VP of Supply Chain & Purchasing (Age 43)

Who are Innophos' major shareholders?

Innophos' stock is owned by a variety of of institutional and retail investors. Top institutional investors include Confluence Investment Management LLC (0.76%), Foundry Partners LLC (0.69%), Dalton Greiner Hartman Maher & Co. (0.58%), Rhumbline Advisers (0.33%), California Public Employees Retirement System (0.21%) and Synovus Financial Corp (0.08%). View Institutional Ownership Trends for Innophos.

Which major investors are selling Innophos stock?

IPHS stock was sold by a variety of institutional investors in the last quarter, including Municipal Employees Retirement System of Michigan and Confluence Investment Management LLC. View Insider Buying and Selling for Innophos.

Which major investors are buying Innophos stock?

IPHS stock was purchased by a variety of institutional investors in the last quarter, including Foundry Partners LLC, Dalton Greiner Hartman Maher & Co., California Public Employees Retirement System, Synovus Financial Corp, Russell Investments Group Ltd., State of Alaska Department of Revenue, GW&K Investment Management LLC and HGK Asset Management Inc.. View Insider Buying and Selling for Innophos.

How do I buy shares of Innophos?

Shares of IPHS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Innophos' stock price today?

One share of IPHS stock can currently be purchased for approximately $32.03.

How big of a company is Innophos?

Innophos has a market capitalization of $630.70 million and generates $801.84 million in revenue each year. The specialty chemicals company earns $36.07 million in net income (profit) each year or $2.28 on an earnings per share basis. Innophos employs 1,485 workers across the globe.View Additional Information About Innophos.

What is Innophos' official website?

The official website for Innophos is http://www.innophos.com/.

How can I contact Innophos?

Innophos' mailing address is 259 PROSPECT PLAINS ROAD, CRANBURY NJ, 08512. The specialty chemicals company can be reached via phone at 609-495-2495 or via email at [email protected]


MarketBeat Community Rating for Innophos (NASDAQ IPHS)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  321 (Vote Outperform)
Underperform Votes:  312 (Vote Underperform)
Total Votes:  633
MarketBeat's community ratings are surveys of what our community members think about Innophos and other stocks. Vote "Outperform" if you believe IPHS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IPHS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/13/2019 by MarketBeat.com Staff

Featured Article: What is a Special Dividend?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel